Actelion shares gain on report of progress in Sanofi talks

ZURICH, Dec 21 (Reuters) - Swiss biotech group Actelion's

shares rose by more than 3 percent on Wednesday

following a report that talks with Sanofi are making

progress, increasing optimism that the two will strike a deal.

Read more